Antonio Javier Vallejo Vaz

Beatriz Galindo (Investigador distinguido)
avallejo1@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin Grupo
Instituto de Inv.: IBIS
Tipo Año Título Fuente
Artículo2022 Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study LANCET
Artículo2021 A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia ATHEROSCLEROSIS
Revisión2021 Cerebrovascular disease and statins FRONTIERS IN CARDIOVASCULAR MEDICINE
Resumen congreso2021 Comparison of achieving 2019 ESC/EAS versus 2018 ACC/AHA LDL-C goals for patients with atherosclerotic cardiovascular disease: a cardiovascular risk simulation from the Da Vinci study JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Artículo2021 Effect of computerised, knowledge-based, clinical decision support systems on patient-reported and clinical outcomes of patients with chronic disease managed in primary care settings: A systematic review BMJ OPEN
Artículo2021 Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) LANCET
Artículo2021 LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial ATHEROSCLEROSIS
Artículo2021 Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: the ICARIA study ATHEROSCLEROSIS
Revisión2020 Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia? CURRENT OPINION IN LIPIDOLOGY
Revisión2020 Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis CIRCULATION
Revisión2020 Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action JAMA CARDIOLOGY
Artículo2020 Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
Revisión2020 Triglycerides and residual risk CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
Artículo2019 A multidisciplinary approach for patients with multiple chronic conditions: IMPACTO study MEDICINA CLINICA
Artículo2019 Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control ATHEROSCLEROSIS
Resumen congreso2019 LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL ATHEROSCLEROSIS
Artículo2019 Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials ATHEROSCLEROSIS
Resumen congreso2019 PREMATURE MORBIDITY AND MORTALITY AMONG DIAGNOSED AND POTENTIALLY UNDIAGNOSED FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS IN THE GENERAL POPULATION: AN OBSERVATIONAL STUDY OF OVER 1.7 MILLION HEALTH RECORDS ATHEROSCLEROSIS
Revisión2018 Epidemiology of familial hypercholesterolaemia: Community and clinical ATHEROSCLEROSIS
Artículo2018 Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials JOURNAL OF THE AMERICAN HEART ASSOCIATION
Artículo2018 Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) ATHEROSCLEROSIS
Editorial2018 Reducing Risk in Familial Hypercholesterolaemia and Severe Dyslipidaemia: Novel Drugs Targeting PCSK9 EUROPEAN CARDIOLOGY REVIEW
Letter2018 Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up" CIRCULATION
Artículo2018 Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial CIRCULATION
Artículo2017 Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up CIRCULATION
Resumen congreso2017 LOWER ON-TREATMENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL IS ASSOCIATED WITH LOWER CARDIOVASCULAR RISK IN VERY HIGH RISK PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: ANALYSES FROM THE ODYSSEY TRIALS JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Resumen congreso2017 LOWER ON-TREATMENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL IS ASSOCIATED WITH LOWER CARDIOVASCULAR RISK IN WOMEN: ANALYSES FROM THE ODYSSEY TRIALS OF ALIROCUMAB VERSUS CONTROL JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Resumen congreso2017 PREDICTIVE FACTORS FOR ALIROCUMAB DOSE INCREASE IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA ATHEROSCLEROSIS
Resumen congreso2017 Predictive factors for alirocumab dose increase in patients with hypercholesterolaemia and high cardiovascular risk: from the ODYSSEY COMBO I and II trials EUROPEAN HEART JOURNAL
Resumen congreso2017 Predictive Factors of the Magnitude of Response to Alirocumab Dose Increase in Patients With Dyslipidemia CIRCULATION
Artículo2017 Relation of Fasting Triglyceride-Rich Lipoprotein Cholesterol to Coronary Artery Calcium Score (from the ELSA-Brasil Study) AMERICAN JOURNAL OF CARDIOLOGY
Artículo2017 Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome AMERICAN JOURNAL OF HYPERTENSION
Resumen congreso2016 CELL-DERIVED MICROPARTICLES AS MARKERS OF ENDOTHELIAL FUNCTION, INFLAMMATION AND COAGULATION IN PATIENTS WITH SLEEP APNEA-HYPOPNEA SYNDROME: A SYSTEMATIC REVIEW ATHEROSCLEROSIS
Artículo2016 Disfunción endotelial medida con flujimetría láser-doppler en pacientes con síndrome de apneas-hipopneas del sueño: efecto del tratamiento con presión positiva continua en la vía aérea Revista Española de Patología Torácica
Revisión2016 Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials PHARMACOLOGICAL RESEARCH
Revisión2016 Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1 A systematic review and meta-analysis of randomised controlled trials THROMBOSIS AND HAEMOSTASIS
Artículo2016 Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration ATHEROSCLEROSIS SUPPLEMENTS
Editorial2016 Promoting high-density lipoprotein function via intravenous infusion: the rebirth of apoA-I Milano? EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
Resumen congreso2016 Relationship between triglyceride-rich lipoprotein cholesterol concentrations and non-RDL cholesterol goal attainment in ODYSSEY phase 3 trials DIABETOLOGIA
Editorial2015 Cholesterol Efflux Capacity as a Novel Biomarker for Incident Cardiovascular Events Has High-Density Lipoprotein Been Resuscitated? CIRCULATION RESEARCH
Artículo2015 Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes ATHEROSCLEROSIS
Resumen congreso2015 EFFECTS OF PITAVASTATIN THERAPYON GLUCOSE, HBA1C AND INCIDENCE OF DIABETES MELLITUS: A META-ANALYSIS OF RANDOMIZED CONTROLLED CLINICAL TRIALS IN NON-DIABETIC INDIVIDUALS ATHEROSCLEROSIS
Resumen congreso2015 EVALUATION OF CIRCULATING CELL-FREE DNA LEVELS IN PATIENTS WITH SEVERE PREECLAMPSIA AND HELLP SYNDROME ATHEROSCLEROSIS
Artículo2015 Familial hypercholesterolaemia: A global call to arms ATHEROSCLEROSIS
Resumen congreso2015 LEVELS OF CIRCULATING CELL-FREE DNA IN PATIENTS WITH SLEEP APNEA-HYPOPNEA SYNDROME WITH OR WITHOUT HYPERTENSION AND TREATMENT WITH CONTINUOUS POSITIVE AIRWAY PRESSURE JOURNAL OF HYPERTENSION
Artículo2015 Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary ATHEROSCLEROSIS
Artículo2015 Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides - The Case for Soluble ST2 EUROPEAN CARDIOLOGY REVIEW
Resumen congreso2015 OBSTRUCTIVE SLEEP APNOEA SYNDROME, ENDOTHELIAL FUNCTION AND MARKERS OF ENDOTHELIALIZATION. CHANGES AFTER CPAP ATHEROSCLEROSIS
Artículo2015 Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP PLOS ONE
Resumen congreso2015 RELATIONSHIP OF NON-HDL-CHOLESTEROL LEVELS AND GOAL ATTAINMENT WITH TRIGLYCERIDES AND REMNANT LIPOPROTEINS IN A NATIONWIDE SURVEY OF OVER 2600 DIABETIC SUBJECTS WITH CARDIOVASCULAR DISEASE ATHEROSCLEROSIS
Editorial2015 The evolving role of CETP inhibition: beyond HDL cholesterol LANCET
Resumen congreso2015 TREATMENT WITH CONTINUOUS POSITIVE AIRWAY PRESSURE AND CHANGES IN GLUCOSE METABOLISM AND INSULIN RESISTANCE IN PATIENTS WITH SLEEP APNEA-HYPOPNEA SYNDROME JOURNAL OF HYPERTENSION
Artículo2014 Maternal Body-Mass Index and Cord Blood Circulating Endothelial Colony-Forming Cells JOURNAL OF PEDIATRICS
Artículo2013 Coexistence of two causes of secondary hypertension in a single patient REVISTA CLINICA ESPANOLA
Letter2013 Isolated abducens nerve palsy in preeclampsia and hypertension in pregnancy HYPERTENSION RESEARCH
Revisión2013 Obstructive Sleep Apnea Syndrome, Vascular Pathology, Endothelial Function and Endothelial Cells and Circulating Microparticles ARCHIVES OF MEDICAL RESEARCH
Artículo2013 Role of Circulating Cell-free DNA Levels in Patients With Severe Preeclampsia and HELLP Syndrome AMERICAN JOURNAL OF HYPERTENSION
Artículo2012 Abnormal levels of antioxidant defenses in a large sample of patients with hypertensive disorders of pregnancy HYPERTENSION RESEARCH
Artículo2012 Olive Oil Polyphenols Decrease Blood Pressure and Improve Endothelial Function in Young Women with Mild Hypertension AMERICAN JOURNAL OF HYPERTENSION
Artículo2012 Which parameter is better to define endothelial dysfunction in a test of postocclusive hyperemia measured by Laser-Doppler flowmetry? CORONARY ARTERY DISEASE
Revisión2011 Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome INTERNATIONAL JOURNAL OF HYPERTENSION
Artículo2011 The HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): Clinical characteristics and maternal-fetal outcome in 172 patients PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH
Artículo2011 The postprandial state and its influence on the development of atherosclerosis Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry
Letter2011 Uveítis anterior bilateral e infección por Rickettsia typhi Enfermedades infecciosas y microbiología clínica
Resumen congreso2010 CLINICAL-BIOLOGICAL PROFILE OF A GROUP OF PATIENTS WITH PLASMACYTOMAS: A REVIEW OF HOMING BEHAVIOUR IN 68 PATIENTS WITH MULTIPLE MYELOMA HAEMATOLOGICA
Artículo2010 Differences in the prevalence of metabolic syndrome and levels of C-reactive protein after puerperium in women with hypertensive disorders during pregnancy HYPERTENSION RESEARCH
Resumen congreso2010 Study of a series of 172 cases of hellp syndrome as a severe complication of hypertension in pregnancy JOURNAL OF HYPERTENSION
Resumen congreso2009 24-hour blood pressure monitoring and biochemical parameters in pregnant women with preeclampsia at diagnosis and after puerperium JOURNAL OF HYPERTENSION
Letter2009 Fistulating bowel disease and abscess due to neuromuscular hamartoma of ileum and cecum MEDICINA CLINICA
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado